Related Experiment Videos
P-glycoprotein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy
L Kostakoglu1, D Guc, H Canpinar
1Department of Nuclear Medicine, Hacettepe University Medical Faculty, Ankara, Turkey.
Summary
Technetium-99m-methoxyisobutyl isonitrile (99mTc-MIBI) imaging shows an inverse correlation with p-glycoprotein (Pgp) expression in hematologic malignancy patients. This suggests 99mTc-MIBI imaging can detect Pgp in vivo.
Area of Science:
- Nuclear medicine
- Oncology
- Molecular biology
Background:
- P-glycoprotein (Pgp) is a key factor in multidrug resistance in hematologic malignancies.
- Accurate assessment of Pgp expression is crucial for treatment strategies.
Purpose of the Study:
- To investigate the relationship between 99mTc-MIBI uptake and Pgp expression levels.
- To evaluate the utility of 99mTc-MIBI imaging for in vivo Pgp detection in hematologic malignancy.
Main Methods:
- Analyzed 21 samples from 19 patients with hematologic malignancy.
- Assessed 99mTc-MIBI uptake using qualitative and quantitative imaging analyses.
- Determined Pgp expression via flow cytometry and RT-PCR.
Main Results:
- Found an inverse correlation between Pgp levels and 99mTc-MIBI uptake (p=0.022).
- Significant differences in MIBI uptake between Pgp-positive and Pgp-negative groups (p=0.009, p=0.024).
- RT-PCR showed statistical support for a difference in qualitative analysis (p=0.061).
Conclusions:
- 99mTc-MIBI imaging correlates strongly with flow cytometry for Pgp detection.
- Imaging shows potential for in vivo Pgp assessment in hematologic malignancies.
- MIBI imaging may aid in guiding therapy for patients with hematologic malignancy.